ATOS Atossa Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 7, 2026
$2,34
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$1,7052 haftanın en düşüğü
$19,3552 haftanın en yükseği
Piyasa Değeri (MRQ)
$23M
P/E
-0.6
Hisse Başına Kâr
$-4.04
rozetleriniz
52 Haftlık Aralık
$2–$19
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$19
P/E
-0.6
ROE
-71.7%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
ATOS Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$2.34
Piyasa Değeri (MRQ)
$23M
P/E
-0.6
Hisse Başına Kâr
$-4.04
ROE
-71.7%
52 Haftlık Aralık
$2–$19
ATOS Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 02 Şubat 2026 | 1-for-15 | Ters |
| 20 Nisan 2018 | 1-for-12 | Ters |
| 26 Ağustos 2016 | 1-for-15 | Ters |
Atossa Therapeutics, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
sektörHealthcare
endüstriBiotechnology
çalışanlar16
ülkeUS
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Hisse Başına Kâr$-4.042022-12-31 → 2025-12-31
Serbest Nakit Akışı$-30M2018-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | ATOS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -0.65Y ort. ≈-1.7 | ≈-1.7 | · | · | |
| P/S (F/S) | 176.75Y ort. ≈888.4 | ≈888.4 | 62.2 | Düşük değerli | |
| F/D (MRQ) | 0.95Y ort. ≈1.0 | ≈1.0 | 1.1 | Düşük değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | -0.75Y ort. ≈-5.3 | ≈-5.3 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -0.75Y ort. ≈-5.3 | ≈-5.3 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 0.55Y ort. ≈1.0 | ≈1.0 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | ATOS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -56.1%5Y ort. ≈-31.1% | ≈-31.1% | -56.1% | Aynı seviyede | |
| ROE | -71.7%5Y ort. ≈-35.1% | ≈-35.1% | -128.2% | En üst düzey | |
| ROIC | -94.4%5Y ort. ≈-41.2% | ≈-41.2% | -77.4% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | ATOS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 5.75Y ort. ≈20.9 | ≈20.9 | 2.1 | Güçlü likidite | |
| Quick Ratio (Cari Oran) | 5.05Y ort. ≈20.0 | ≈20.0 | 1.6 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-8.6%
Sonraki Rapor
Kas 10, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 10, 2026 | $-0.95 | $-1.05 | 9.1% |
| 31 Mart 2026 | May 11, 2026 | $-1.11 | $-6.25 | 82.2% |
| 31 Aralık 2025 | $-3.08 | $-1.16 | -165.4% | |
| 30 Eylül 2025 | $-1.05 | $-1.02 | -2.9% | |
| 30 Haziran 2025 | $-1.05 | $-0.88 | -19.3% | |
| 31 Mart 2025 | $-0.75 | $-0.87 | 13.5% | |
| 31 Aralık 2024 | $-0.75 | $-0.97 | 22.6% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | $1.8K | $40.1K | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | $132.4K | $0 | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | $-130.7K | $40.1K | |
| R&D Expense | $21M | $14M | $17M | $15M | $9M | $7M | $7M | $4M | $2M | $770.4K | $2M | $1M | |
| SG&A Expense | $16M | $14M | $14M | $13M | $11M | $8M | $11M | $7M | $5M | $6M | $9M | $8M | |
| Operating Expenses | $37M | $28M | $31M | $28M | $21M | $15M | $17M | $11M | $8M | $8M | $13M | $12M | |
| Operating Income | $-37M | $-28M | $-31M | $-28M | $-21M | $-15M | $-17M | $-11M | $-8M | $-8M | $-13M | $-12M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $15.8K | |
| Interest Income | $2M | $4M | $4M | $877.0K | $6.0K | · | · | · | · | · | · | $260 | |
| Other Non-op | $-6.0K | $-223.0K | $-70.0K | $-146.0K | $-91.0K | $51.0K | $25.6K | $29.3K | $154 | $2M | $431 | $260 | |
| Pretax Income | $-35M | $-26M | $-30M | $-27M | $-21M | $-18M | $-17M | $-11M | $-8M | $-6M | $-13M | $-12M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $0 | |
| Net Income | $-35M | $-26M | $-30M | $-27M | $-21M | $-18M | $-17M | $-11M | $-8M | $-6M | $-16M | $-15M | |
| EPS (Basic) | $-4.04 | $-3.04 | $-0.24 | $-0.21 | $-0.18 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-4.04 | $-3.04 | $-0.24 | $-0.21 | · | · | · | · | · | · | · | · | |
| Shares (Basic) | 8,611,321 | 8,390,618 | 126,081,602 | 126,624,110 | 116,950,000 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 8,611,321 | 8,390,618 | 126,081,602 | 126,624,110 | · | · | · | · | · | · | · | · | |
| EBITDA | $-37M | $-28M | $-31M | $-28M | $-20M | $-15M | $-17M | $-11M | $-8M | $-8M | $-12M | $-14M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $71M | $88M | $111M | $136M | $40M | $13M | $10M | $7M | $3M | $4M | $9M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | $298.0K | |
| Inventory | · | · | · | · | · | · | · | · | · | · | $0 | $9.3K | |
| Prepaid Expense | $1M | $1M | $2M | $1M | $2M | $2M | $862.3K | $509.8K | $250.9K | $171.6K | $193.3K | $194.0K | |
| Other Current Assets | · | · | · | $2M | $1M | $657.0K | $26.1K | $30.9K | $16.3K | · | $110.7K | $0 | |
| Current Assets | $46M | $74M | $92M | $118M | $141M | $43M | $14M | $12M | $8M | $3M | $4M | $9M | |
| PP&E (Net) | · | · | · | · | $20.0K | $21.0K | $34.4K | $54.5K | $11.5K | $55.1K | $171.6K | $136.7K | |
| PP&E (Gross) | · | · | · | · | $36.0K | $186.0K | $185.5K | $216.0K | $171.0K | $210.5K | $285.9K | $456.7K | |
| Accum. Depreciation | · | · | · | · | $16.0K | $165.0K | $151.2K | $162.0K | $160.0K | $155.4K | $114.3K | $320.0K | |
| Intangibles | · | · | · | · | $54.0K | $41.0K | $173.5K | $192.0K | $234.0K | $640.4K | $2M | $2M | |
| Other Non-current Assets | $2M | $2M | $2M | $635.0K | $22.0K | $17.0K | $17.2K | $17.2K | $178.9K | $194.2K | $76.3K | $48.2K | |
| Total Assets | $48M | $76M | $96M | $124M | $141M | $43M | $14M | $12M | $8M | $4M | $6M | $12M | |
| Accounts Payable | $4M | $679.0K | $806.0K | $3M | $2M | $2M | $293.2K | $353.3K | $334.9K | $254.3K | $814.4K | $513.0K | |
| Accrued Liabilities | $1M | $919.0K | $973.0K | $1M | $204.0K | $93.0K | $77.9K | $177.1K | $90.1K | $17.0K | $463.7K | $254.1K | |
| Current Liabilities | $8M | $5M | $5M | $6M | $3M | $16M | $1M | $3M | $1M | $1M | $3M | $2M | |
| Capital Leases | · | · | · | · | · | · | $11.1K | · | · | · | · | · | |
| Total Liabilities | $8M | $5M | $5M | $6M | $3M | $16M | $1M | $3M | · | $1M | $3M | $2M | |
| Common Stock | $2M | $2M | $23M | $23M | $23M | $9M | $2M | $1M | $477.3K | $56.8K | $32.7K | $24.6K | |
| Paid-in Capital | $286M | $283M | $256M | $251M | · | $130M | · | · | $72M | $60M | $55M | $45M | |
| Retained Earnings | $-247M | $-212M | $-186M | $-156M | $-129M | $-112M | $-94M | $-77M | $-65M | $-57M | $-51M | $-35M | |
| Treasury Stock | $1M | $1M | $1M | $0 | · | · | · | · | · | · | · | · | |
| AOCI | · | · | · | · | $0 | · | · | · | · | · | · | · | |
| Stockholders' Equity | $39M | $71M | $91M | $118M | $138M | $27M | $13M | $9M | $7M | $3M | $4M | $9M | |
| Liabilities + Equity | $48M | $76M | $96M | $124M | $141M | $43M | $14M | $12M | $8M | $4M | $6M | $12M | |
| Shares Outstanding | 8,611,361 | 8,611,266 | 125,304,064 | 126,624,110 | 126,624,000 | 47,550,000 | 9,130,984 | 5,846,552 | 2,651,952 | 3,786,913 | 2,177,151 | 24,564,058 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $8.0K | $23.0K | $47.0K | $52.8K | $44.2K | $129.0K | $303.5K | $272.6K | $480.3K | |
| Stock-based Comp | $3M | $2M | $5M | $7M | · | · | · | · | · | · | $840.1K | $556.3K | |
| Amort. of Intangibles | · | · | · | · | · | $27.6K | $30.8K | $30.0K | $103.0K | · | · | · | |
| Other Non-cash | · | · | · | $6M | $4M | $6M | $8M | $2M | $1M | $690.8K | $694.3K | $3M | |
| Operating Cash Flow | $-30M | $-21M | $-21M | $-21M | $-16M | $-12M | $-9M | $-9M | $-7M | $-5M | $-14M | $-11M | |
| CapEx | $23.0K | $19.0K | $14.0K | $27.0K | $9.0K | $9.0K | $7.6K | $110.9K | · | · | · | · | |
| Investing Cash Flow | $-23.0K | $-19.0K | $-14.0K | $-5M | $-9.0K | $-9.0K | $-7.6K | $-110.9K | · | $-9.2K | $-288.4K | $-343.3K | |
| Stock Issued | · | · | · | · | · | · | · | · | $6M | $5M | $9M | $13M | |
| Stock Repurchased | · | $0 | $1M | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $0 | $-1M | · | · | · | · | · | $6M | $5M | $9M | · | |
| Financing Cash Flow | $0 | $4M | $-1M | $0 | $113M | $39M | $11M | $12M | $11M | $5M | · | · | |
| Net Change in Cash | $-30M | $-17M | $-22M | $-25M | $97M | $27M | $2M | $3M | $4M | $-687.9K | $-5M | $2M | |
| Free Cash Flow | $-30M | $-21M | $-21M | $-21M | $-16M | $-12M | $-9M | $-9M | · | · | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | · | · | -7431.9% | 35.2% | |
| Operating Margin | · | · | · | · | · | · | · | · | · | · | -725746.2% | -2784.0% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | -896491.6% | -2786.9% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | -725721.7% | -2786.9% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | -710238.4% | -2676.7% | |
| ROA | -56.1% | -29.5% | -27.4% | -20.4% | -22.4% | -62.2% | -131.5% | -114.7% | -132.0% | -122.6% | -175.0% | -123.3% | |
| ROE | -71.7% | -35.1% | -31.8% | -22.3% | -14.8% | -96.3% | -122.4% | -117.7% | -161.9% | -186.3% | -238.1% | -145.8% | |
| ROIC | -94.4% | -38.6% | -34.5% | -23.5% | -14.9% | -53.8% | -131.2% | -129.9% | · | · | -341.0% | -154.2% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.5 | 15.0 | 17.6 | 21.2 | 45.2 | 2.7 | 10.8 | 4.0 | 6.4 | 3.1 | 1.7 | 4.1 | |
| Quick Ratio | 5.0 | 14.3 | 16.9 | 19.9 | 43.6 | 2.5 | 9.5 | 3.6 | 5.9 | 2.9 | 1.5 | 4.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -928.6 |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | · | 28.5 | 17.1 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | 2.4 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.57 | $0.55 | $0.73 | $0.93 | $1.09 | $0.57 | $1.44 | $1.51 | $0.22 | $0.82 | $0.11 | $0.39 | |
| Cash Flow / Share | $-3.46 | $-0.17 | $-0.17 | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $4.80 | $0.55 | $0.71 | $0.88 | $1.08 | $0.83 | $1.38 | $1.78 | $0.23 | $0.80 | $0.11 | $0.35 | |
| EPS (TTM) | $-4.04 | $-3.04 | $-0.24 | $-0.21 | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $114.0K | $114.0K | $114.0K | $114.0K | $114.0K | $114.0K | $114.0K | $114.0K | $114.0K | $114.0K | $1.8K | $40.1K | |
| Net Income TTM | $-35M | $-26M | $-30M | $-27M | $-21M | $-18M | $-17M | $-11M | $-8M | $-6M | $-16M | $-15M | |
| Market Cap | $5M | $121M | $110M | $67M | $203M | $45M | $14M | $6M | $99M | $64M | $1.88B | $6.32B | |
| P/E | -0.1 | -0.3 | -3.7 | -2.5 | · | · | · | · | · | · | · | · | |
| P/S | 44.6 | 1064.9 | 967.1 | 588.6 | 1776.8 | 396.2 | 125.7 | 52.3 | 870.8 | 561.9 | 1069998.9 | 157526.2 | |
| P/B | 0.1 | 1.7 | 1.2 | 0.6 | 1.5 | 1.7 | 1.1 | 0.7 | 14.3 | 20.7 | 502.7 | 665.7 | |
| P / Tangible Book | 0.1 | 1.7 | 1.2 | 0.6 | 1.5 | 1.7 | · | · | · | · | · | · | |
| P / Cash Flow | -0.2 | -5.8 | -5.3 | -3.2 | -12.3 | -3.9 | -1.6 | -0.7 | -15.1 | -11.9 | -134.8 | -599.0 | |
| P / FCF | -0.2 | -5.8 | -5.3 | -3.2 | -12.3 | -3.9 | -1.6 | -0.7 | · | · | · | · | |
| Earnings Yield | -684.8% | -323.4% | -27.3% | -39.6% | · | · | · | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $5M | $5M | $6M | $5M | $6M | $4M | $3M | $3M | $4M | $4M | $6M | $4M | $4M | $4M | $5M | $5M | |
| SG&A Expense | $4M | $5M | $5M | $4M | $4M | $3M | $4M | $3M | $4M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | |
| Operating Expenses | $9M | $10M | $11M | $9M | $9M | $7M | $7M | $6M | $7M | $7M | $9M | $7M | $8M | $7M | $8M | $8M | |
| Operating Income | $-9M | $-10M | $-11M | $-9M | $-9M | $-7M | $-7M | $-6M | $-7M | $-7M | $-9M | $-7M | $-8M | $-7M | $-8M | $-8M | |
| Interest Income | $227.0K | $309.0K | $442.0K | $570.0K | $645.0K | $720.0K | $838.0K | $1M | $1M | $1M | $1M | $1M | $983.0K | $850.0K | $671.0K | $194.0K | |
| Other Non-op | $-24.0K | $-28.0K | $57.0K | $-11.0K | $-28.0K | $-24.0K | $-34.0K | $-136.0K | $-17.0K | $-36.0K | $28.0K | $-35.0K | $-30.0K | $-33.0K | $-18.0K | $0 | |
| Pretax Income | $-8M | $-10M | $-11M | $-9M | $-8M | $-7M | $-6M | $-7M | $-6M | $-6M | $-8M | $-6M | $-10M | $-6M | $-7M | $-8M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-8M | $-10M | $-11M | $-9M | $-8M | $-7M | $-6M | $-7M | $-6M | $-6M | $-8M | $-6M | $-10M | $-6M | $-7M | $-8M | |
| EPS (Basic) | $-0.95 | $-1.11 | $-3.85 | $-0.07 | $-0.98 | $-0.78 | $-2.88 | $-0.06 | $-0.05 | $-0.05 | $-0.06 | $-0.05 | $-0.08 | $-0.05 | $-0.06 | $-0.06 | |
| EPS (Diluted) | $-0.95 | $-1.11 | $-3.85 | $-0.07 | $-0.98 | $-0.78 | $-2.88 | $-0.06 | $-0.05 | $-0.05 | $-0.06 | $-0.05 | $-0.08 | $-0.05 | · | · | |
| Shares (Basic) | 8,908,511 | 8,622,289 | · | 129,171,424 | 8,622,289 | 8,622,289 | · | 125,772,664 | 125,732,140 | 125,319,778 | · | 125,793,112 | 126,622,798 | 126,624,110 | · | 126,624,000 | |
| Shares (Diluted) | 8,908,511 | 8,622,289 | · | 129,171,424 | 8,622,289 | 8,622,289 | · | 125,772,664 | 125,732,140 | 125,319,778 | · | 125,793,112 | 126,622,798 | 126,624,110 | · | · | |
| EBITDA | $-9M | $-10M | · | $-9M | $-9M | $-7M | · | $-6M | $-7M | $-7M | · | $-7M | $-8M | $-7M | · | $-8M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $26M | $32M | $41M | $52M | $58M | $65M | $71M | $75M | $80M | $84M | $88M | $94M | $99M | $104M | $111M | $117M | |
| Prepaid Expense | $2M | $2M | $1M | $580.0K | $1M | $1M | $1M | $950.0K | $987.0K | $2M | $2M | $3M | $6M | $5M | $1M | $5M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $7.0K | $7.0K | $858.0K | · | $201.0K | |
| Current Assets | $31M | $37M | $46M | $56M | $63M | $69M | $74M | $77M | $82M | $87M | $92M | $98M | $106M | $111M | $118M | $123M | |
| Other Non-current Assets | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $642.0K | $631.0K | $635.0K | $629.0K | |
| Total Assets | $32M | $38M | $48M | $58M | $65M | $71M | $76M | $79M | $86M | $91M | $96M | $102M | $108M | $116M | $124M | $127M | |
| Accounts Payable | $2M | $3M | $4M | $4M | $2M | $1M | $679.0K | $2M | $1M | $1M | $806.0K | $718.0K | $1M | $1M | $3M | $2M | |
| Accrued Liabilities | $1M | $3M | $1M | $2M | $2M | $2M | $919.0K | $2M | $2M | $2M | $973.0K | $1M | $803.0K | $613.0K | $1M | $117.0K | |
| Current Liabilities | $5M | $7M | $8M | $8M | $7M | $5M | $5M | $6M | $6M | $5M | $5M | $3M | $3M | $3M | $6M | $3M | |
| Total Liabilities | $5M | $7M | $8M | $8M | $7M | $5M | $5M | $6M | $6M | $5M | $5M | $3M | $3M | $3M | $6M | $3M | |
| Common Stock | $2M | $2M | $2M | $23M | $23M | $23M | $2M | $23M | $23M | $23M | $23M | $23M | $23M | $23M | $23M | $23M | |
| Paid-in Capital | $291M | $287M | $286M | $263M | $263M | $262M | $283M | $258M | $257M | $257M | $256M | · | · | · | $251M | · | |
| Retained Earnings | $-265M | $-256M | $-247M | $-236M | $-227M | $-219M | $-212M | $-205M | $-198M | $-192M | $-186M | $-179M | $-172M | $-162M | $-156M | $-149M | |
| Treasury Stock | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $152.0K | · | $0 | · | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-54.0K | |
| Stockholders' Equity | $27M | $30M | $39M | $50M | $58M | $65M | $71M | $74M | $80M | $86M | $91M | $98M | $105M | $113M | $118M | $124M | |
| Liabilities + Equity | $32M | $38M | $48M | $58M | $65M | $71M | $76M | $79M | $86M | $91M | $96M | $102M | $108M | $116M | $124M | $127M | |
| Shares Outstanding | 9,979,298 | 8,611,361 | 8,611,361 | 129,171,424 | 129,171,424 | 129,170,004 | 8,611,266 | 125,304,064 | 125,304,064 | 125,507,814 | 125,304,064 | 125,304,000 | 126,505,000 | 126,624,000 | 126,624,110 | 126,624,000 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $3.0K | $3.0K | $3.0K | · | $2.0K | |
| Stock-based Comp | $815.0K | $722.0K | $503.0K | $784.0K | $796.0K | $563.0K | $774.0K | $749.0K | $352.0K | $417.0K | $519.0K | $926.0K | $2M | $2M | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $-744.0K | · | · | |
| Operating Cash Flow | $-10M | $-10M | $-11M | $-6M | $-7M | $-6M | $-7M | $-5M | $-5M | $-5M | $-6M | $-4M | $-4M | $-7M | $-5M | $-5M | |
| CapEx | $0 | $0 | $7.0K | $7.0K | $0 | $9.0K | $0 | $10.0K | $3.0K | $6.0K | $0 | $1.0K | $13.0K | $0 | $8.0K | $6.0K | |
| Investing Cash Flow | $0 | $0 | $-7.0K | $-7.0K | $0 | $-9.0K | $0 | $-10.0K | $-3.0K | $-6.0K | $0 | $-1.0K | $-13.0K | $0 | $-2M | $-3M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $0 | · | |
| Financing Cash Flow | $4M | $0 | $0 | $0 | $0 | $0 | $3M | $0 | $100.0K | $204.0K | $0 | $-1M | $0 | $0 | $0 | $0 | |
| Net Change in Cash | $-6M | $-10M | $-11M | $-6M | $-7M | $-6M | $-4M | $-5M | $-4M | $-4M | $-6M | $-5M | $-4M | $-7M | $-6M | $-8M | |
| Free Cash Flow | · | $-10M | · | · | · | $-6M | · | · | · | $-5M | · | · | · | $-7M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -17.5% | -17.6% | · | -12.6% | -11.2% | -8.3% | · | -8.0% | -6.2% | -5.7% | · | -5.5% | -8.1% | -5.0% | · | -5.9% | |
| ROE | -20.1% | -20.0% | · | -14.1% | -12.2% | -8.9% | · | -8.4% | -6.5% | -5.9% | · | -5.6% | -8.4% | -5.1% | · | -6.0% | |
| ROIC | -32.4% | -32.4% | · | -18.6% | -15.7% | -11.3% | · | -8.7% | -8.9% | -8.1% | · | -7.6% | -7.4% | -6.3% | · | -6.6% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.7 | 4.9 | · | 6.8 | 9.2 | 12.7 | · | 13.3 | 14.3 | 16.3 | · | 28.4 | 30.5 | 37.7 | · | 43.0 | |
| Quick Ratio | 4.8 | 4.3 | · | 6.3 | 8.5 | 12.0 | · | 12.9 | 14.0 | 15.8 | · | 27.3 | 28.6 | 35.3 | · | 40.9 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.69 | $3.54 | · | $0.39 | $0.45 | $0.51 | · | $0.59 | $0.64 | $0.68 | · | $0.78 | $0.83 | $0.89 | · | $0.98 | |
| Cash Flow / Share | · | $-1.11 | · | · | · | $-0.05 | · | · | · | $-0.04 | · | · | · | · | · | · | |
| Cash / Share | $2.61 | $3.68 | · | $0.40 | $0.45 | $0.50 | · | $0.60 | $0.63 | $0.67 | · | $0.75 | $0.79 | $0.82 | · | $0.93 | |
| EPS (TTM) | $-5.98 | $-6.01 | · | $-4.71 | $-4.70 | $-3.77 | · | $-0.22 | $-0.21 | $-0.24 | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-38M | $-38M | · | $-30M | $-29M | $-26M | · | $-27M | $-26M | $-30M | · | $-30M | $-32M | $-28M | · | $-24M | |
| Market Cap | $19M | $45M | · | $112M | $107M | $87M | · | $190M | $149M | $226M | · | $93M | $159M | $91M | · | $105M | |
| P/E | -0.3 | -0.9 | · | -2.8 | -2.6 | -2.7 | · | -103.6 | -85.0 | -112.5 | · | · | · | · | · | · | |
| P/B | 0.7 | 1.5 | · | 2.3 | 1.9 | 1.3 | · | 2.6 | 1.9 | 2.6 | · | 0.9 | 1.5 | 0.8 | · | 0.8 | |
| P / Tangible Book | 0.7 | 1.5 | · | 2.3 | 1.9 | 1.3 | · | 2.6 | 1.9 | 2.6 | · | 0.9 | 1.5 | 0.8 | · | 0.8 | |
| P / Cash Flow | · | -4.7 | · | · | · | -14.5 | · | · | · | -48.1 | · | · | · | -13.0 | · | · | |
| Earnings Yield | -309.8% | -114.3% | · | -36.1% | -37.8% | -37.5% | · | -0.96% | -1.2% | -0.89% | · | · | · | · | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Gelir | $-35M | $-26M | $-30M | $-27M | $-21M |
| Seyreltilmiş Hisse Başı Kâr | $-4.04 | $-3.04 | $-0.24 | $-0.21 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 5.5 | 15.0 | 17.6 | 21.2 | 45.2 |
| Cari Oran | 5.0 | 14.3 | 16.9 | 19.9 | 43.6 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-30M | $-21M | $-21M | $-21M | $-16M |
Kurumsal Sahipler (13F) 40 dosya · $6.4M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
40
Tutulan Değer
$6.4M
Yeni pozisyonlar
7
Çıkan pozisyonlar
6
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 7 | 6 | 8 | 8 | · |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır. Önceki çeyreğe göre değişim gösterilmiyor: başvuru sahibi kapsamı, güvenilir bir karşılaştırma için bu iki çeyrek arasında çok fazla farklılık göstermektedir.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD GROUP INC | $3.627.225 | 6.147.838 | 56,95% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $698.172 | 361.747 | 10,96% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $498.392 | 258.234 | 7,82% | Hisse senetleri |
| BlackRock, Inc. | $317.211 | 164.358 | 4,98% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $254.843 | 132.043 | 4,00% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $178.343 | 92.382 | 2,80% | Hisse senetleri |
| UBS Group AG | $159.456 | 82.620 | 2,50% | Hisse senetleri |
| JANE STREET GROUP, LLC | $109.242 | 56.602 | 1,72% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $101.485 | 52.583 | 1,59% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $89.760 | 46.508 | 1,41% | Hisse senetleri |
| STATE STREET CORP | $76.739 | 39.761 | 1,20% | Hisse senetleri |
| NORTHERN TRUST CORP | $39.081 | 20.249 | 0,61% | Hisse senetleri |
| Point72 Asia (Singapore) Pte. Ltd. | $38.240 | 44.106 | 0,60% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $30.058 | 15.574 | 0,47% | Hisse senetleri |
| WOLVERINE TRADING, LLC | $24.436 | 28.000 | 0,38% | Satım opsiyonu |
| MORGAN STANLEY | $23.825 | 12.345 | 0,37% | Hisse senetleri |
| WOLVERINE TRADING, LLC | $23.825 | 27.300 | 0,37% | Alım opsiyonu |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $21.809 | 11.300 | 0,34% | Alım opsiyonu |
| WOLVERINE TRADING, LLC | $16.007 | 18.342 | 0,25% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $10.797 | 18.300 | 0,17% | Hisse senetleri |
| GREENBERG FINANCIAL GROUP | $10.747 | 18.216 | 0,17% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $5.962 | 3.089 | 0,09% | Hisse senetleri |
| ROYAL BANK OF CANADA | $4.000 | 1.994 | 0,06% | Hisse senetleri |
| JONES FINANCIAL COMPANIES LLLP | $3.875 | 2.061 | 0,06% | Hisse senetleri |
| MCF Advisors LLC | $2.058 | 1.066 | 0,03% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $1.131 | 587 | 0,02% | Hisse senetleri |
| JPMORGAN CHASE & CO | $772 | 390 | 0,01% | Hisse senetleri |
| Rockefeller Capital Management L.P. | $643 | 333 | 0,01% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $440 | 228 | 0,01% | Hisse senetleri |
| SBI Securities Co., Ltd. | $286 | 148 | 0,00% | Hisse senetleri |
| HARBOUR INVESTMENTS, INC. | $212 | 110 | 0,00% | Hisse senetleri |
| TD Waterhouse Canada Inc. | $210 | 103 | 0,00% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $168 | 87 | 0,00% | Hisse senetleri |
| GROUP ONE TRADING LLC | $104 | 54 | 0,00% | Hisse senetleri |
| Point72 (DIFC) Ltd | $71 | 82 | 0,00% | Hisse senetleri |
| Caitong International Asset Management Co., Ltd | $12 | 6 | 0,00% | Hisse senetleri |
| Napier Financial, LLC | $12 | 6 | 0,00% | Hisse senetleri |
| Bogart Wealth, LLC | $10 | 5 | 0,00% | Hisse senetleri |
| Clearstead Advisors, LLC | $8 | 4 | 0,00% | Hisse senetleri |
| BESSEMER GROUP INC | $0 | 6 | 0,00% | Hisse senetleri |
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Steven C. Quay, Shu-Chih Chen ×2 başvurular | 28 Ocak 2016 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 18 içeriden öğrenenler · 10 yöneticiler · 10 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Steven C Quay | President & CEO | 27 Mart 2026 A | 88.038 | 0 | 0 | $0 |
| Mark James Daniel | Chief Financial Officer | 26 Mart 2026 A | 63.000 | 0 | 0 | $0 |
| Heather Rees | Chief Financial Officer | 15 Mayıs 2025 A | · | 0 | 0 | $0 |
| Gregory L Weaver | Former EVP, CFO, & Director | 15 Kasım 2023 S | 55 | 0 | 0 | $0 |
| Kyle Guse | CFO, Gen Counsel and Secretary | 02 Mart 2023 A | 10.000 | 0 | 0 | $0 |
| Scott Youmans | Chief Operating Officer | 01 Eylül 2015 A | · | 0 | 0 | $0 |
| Christopher S. Destro | SVP, Sales and Marketing | 16 Mart 2015 A | · | 0 | 0 | $0 |
| John E Sawyer | SVP, Global Regulatory Affairs and Quality Assurance | 16 Mart 2015 A | · | 0 | 0 | $0 |
| Peter J. Carbonaro | Sr. Vice President, Operations | 06 Mayıs 2014 A | · | 0 | 0 | $0 |
| Ben R Chen | Sr. VP of Glob. Reg. Affairs | 01 Nisan 2014 A | · | 0 | 0 | $0 |
| Tessa Cigler | Yönetim kurulu üyesi | 12 Mayıs 2026 A | 10.000 | 0 | 0 | $0 |
| Jonathan Finn | Yönetim kurulu üyesi | 12 Mayıs 2026 A | 11.666 | 0 | 0 | $0 |
| Shu-Chih Chen | Yönetim kurulu üyesi | 12 Mayıs 2026 A | 10.000 | 0 | 0 | $0 |
| Stephen J Galli | Yönetim kurulu üyesi | 12 Mayıs 2026 A | 10.006 | 0 | 0 | $0 |
| Lawrence H. Remmel | Yönetim kurulu üyesi | 12 Mayıs 2026 A | 10.683 | 0 | 0 | $0 |
| Richard I Steinhart | Yönetim kurulu üyesi | 12 Mayıs 2026 A | 10.000 | 0 | 0 | $0 |
| Alexander D Cross | Yönetim kurulu üyesi | 15 Mayıs 2013 P | 88.866 | 0 | 0 | $0 |
| John Barnhart | Yönetim kurulu üyesi | 07 Mayıs 2013 A | · | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 3 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
ATOS Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 8 analist
AL
Medyan hedef
$22.00
+840,2%
2 25,0%
Güçlü Al
5 62,5%
Al
1 12,5%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
3 analist · 2026-09-27Ortalama hedef $18.67 +697,7%
← Tüm hedeflerin altında
Mevcut fiyat $2.34
Düşük$10.00
Ortalama$18.67
Yüksek$24.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 7, 2026